ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma.

Michael J Robertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.